Literature DB >> 7976413

Lowering cortisol enhances growth hormone response to growth hormone releasing hormone in healthy subjects.

T G Dinan1, J Thakore, V O'Keane.   

Abstract

Cortisol is known to influence growth hormone release probably by modulating somatostatin tone. We examined the effect of metyrapone (the 11 beta-hydroxylase inhibitor) treatment on growth hormone response to growth hormone releasing hormone (1 microgram kg-1 body wt). Six healthy male subjects were tested on two occasions 1 wk apart. On one occasion they received metyrapone followed by growth hormone releasing hormone and on the other placebo followed by growth hormone releasing hormone. In all subjects metyrapone produced a significant drop in cortisol levels. Together with this drop there was a significant enhancement of growth hormone response to growth hormone releasing hormone. The GH response was negatively correlated with the cortisol level. Growth hormone release in response to growth hormone releasing hormone challenge is thus seen to be heavily influenced by cortisol levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976413     DOI: 10.1111/j.1748-1716.1994.tb09761.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  4 in total

Review 1.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 2.  Carbohydrate ingestion/supplementation or resistance exercise and training.

Authors:  M S Conley; M H Stone
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

3.  Betaine supplementation enhances anabolic endocrine and Akt signaling in response to acute bouts of exercise.

Authors:  Jenna M Apicella; Elaine C Lee; Brooke L Bailey; Catherine Saenz; Jeffrey M Anderson; Stuart A S Craig; William J Kraemer; Jeff S Volek; Carl M Maresh
Journal:  Eur J Appl Physiol       Date:  2012-09-14       Impact factor: 3.078

Review 4.  Corticosteroid-serotonin interactions in depression: a review of the human evidence.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2004-03-09       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.